FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/16/2026
Back to search
Official data from USPTO
BIOCONNECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BIOCONNECTION
ST13
US500000079358195Class
1, 5, 35, 40, 42
Filing
79358195
Registration
7574608
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/17/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 35, 40, 42
Filing date
04/26/2023
Registration date
11/26/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
04/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
26
Owner location
NL
Examiner
BARRETT, LEAH N
Law office
L60
Current location
TMEG LAW OFFICE 106
Holders and representatives
Holders
BioConnection B.V.
Representatives
E. Anthony Figg Rothwell, Figg, Ernst & Manbeck, PC
Technical classification
Nice Classes
Class 1Class 5Class 35Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical additives for use in manufacturing of pharmaceuticals; chemical additives for use in the manufacture of medicaments; chemicals used in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cardiovascular disordersfor treating diabetesfor treating allergiesfor treating hypertensionfor treating asthmafor use in urologyfor use in dermatologyfor treating skin disordersfor peripheral nervous systemfor use in chemotherapyfor the treatment of hyperlipidemiafor the central nervous systemfor treatment of infectious diseasesfor the treatment of viral diseasesfor the treatment of autoimmune diseasesfor the treatment of musculo-skeletal disordersfor the treatment of gastro-intestinal diseasesfor the treatment of immune system related diseases and disorderskidney diseases or disordersdiabete
Class 5
Medicines and pharmaceutical preparationsfor treatment of cardiovascular disordersfor treating diabetesfor treating allergiesfor treating hypertensionfor treating asthmafor use in urologyfor use in dermatologyfor treating skin disordersfor peripheral nervous systemfor use in chemotherapyfor the treatment of hyperlipidemiafor the central nervous systemfor treatment of infectious diseasesfor the treatment of viral diseasesfor the treatment of autoimmune diseasesfor the treatment of musculo-skeletal disordersfor the treatment of gastro-intestinal diseasesfor the treatment of immune system related diseases and disorderskidney diseases or disordersdiabetes; dietary supplements for humans and animals
Class 35
Business consultancy services relating to manufacturing of medicinal and pharmaceutical preparations; business management advice relating to manufacturing business; advertising services; business management
Class 40
Contract manufacturing services in the field of preparing medicines and pharmaceutical products; custom manufacturing of biopharmaceuticals; custom manufacturing of pharmaceutical productsfor treatment of cardiovascular disordersfor treating diabetesfor treating allergiesfor treating hypertensionfor treating asthmafor use in urologyfor use in dermatologyfor treating skin disordersfor peripheral nervous systemfor use in chemotherapyfor the treatment of hyperlipidemiafor the central nervous systemfor treatment of infectious diseasesfor the treatment of viral diseasesfor the treatment of autoimmune diseasesfor the treatment of Musculo-skeletal disordersfor the treatment of gastro-intestinal diseasesfor the treatment of immune system related diseases and disorderskidney diseases or disordersdiabetes; preparing medicines and pharmaceutical products being contract manufacturing servicesalso with the aid of biotechnology
Class 42
Product research and development; research and development in the pharmaceutical and biotechnology field; research and development of new products for others; development of pharmaceutical preparations and medicines; services of bio technicalchemical and pharmaceutical laboratoriesincluding scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparationsas well as providing expert advice in the field of pharmaceutical and veterinary preparations; carrying out early evaluations in the field of new medicines as part of scientific research; development of pharmaceutical preparationsmedicines and medicaments; evaluation of pharmaceutical products as part of scientific analysis and research; research and development in the pharmaceutical field; advice regarding the aforesaid researchdevelopment and analysis services as part of consultations about medicines; advice regarding scientific research and analysis relating to medicines; information with regard to scientific research in the field of biochemistry and biotechnology; scientific researchincluding in the medical sector
Publications
History of USPTO decisions and trademark events.
38 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/30/2026
FIMP
FINAL DISPOSITION PROCESSED
03/30/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/19/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/18/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
11/03/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/25/2024
PUBO
PUBLISHED FOR OPPOSITION
06/25/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/14/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/13/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/30/2024
GNFR
FINAL REFUSAL E-MAILED
01/30/2024
CNFR
FINAL REFUSAL WRITTEN
01/30/2024
DOCK
ASSIGNED TO EXAMINER
01/30/2024
RFNP
REFUSAL PROCESSED BY IB
07/22/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/14/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/26/2023
RFRR
REFUSAL PROCESSED BY MPU
06/25/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/19/2023
CNRT
NON-FINAL ACTION WRITTEN
05/18/2023
DOCK
ASSIGNED TO EXAMINER
05/12/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/17/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/17/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/17/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/17/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/17/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/17/2023
MAFR
APPLICATION FILING RECEIPT MAILED
12/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/23/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/22/2022
Continuous trademark protection
Get notified about every new filing that threatens BIOCONNECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.